LEADER 02110nam  2200433z- 450 
001 9910345965003321
005 20210211
035   $a(CKB)4920000000094064
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/44041
035   $a(oapen)doab44041
035   $a(EXLCZ)994920000000094064
100   $a20202102d2018      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aControversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
210   $cFrontiers Media SA$d2018
215   $a1 online resource (74 p.)
225 1 $aFrontiers Research Topics
311 08$a2-88945-450-9 
330   $aThe use of radical prostatectomy in patients with high risk of recurrence has significantly increased during the past 10 years. Thus, adjuvant radiation as a part of multimodality treatment or salvage radiation at the evidence of prostate-specific antigen (PSA) progression represents mainstay curative-intent options for a great number of prostate cancer patients. Although, few randomized trials and many retrospective studies have been published, many uncertainties still mold the discussions on the best treatment management for men after prostatectomy. This research topic successfully intended to foster discussions on current controversies in the use of postoperative radiotherapy and to present novel perspectives for treatment optimization.
606   $aMedicine$2bicssc
610   $aCholine PET
610   $aIntra-operative radiotherapy
610   $aLH-RH agonists
610   $aprostate cancer
610   $aPSMA
610   $arising PSA
610   $asalvage prostate bed radiotherapy
615  7$aMedicine
700   $aAlan Dal Pra$4auth$01331065
702   $aStephane Supiot$4auth
702   $aThomas Zilli$4auth
906   $aBOOK
912   $a9910345965003321
996   $aControversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer$93040092
997   $aUNINA